Barclays’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
131,802
+79,769
| +153% | +$879K | ﹤0.01% | 2434 |
|
|
2025
Q1 | $464K | Sell |
52,033
-22,757
| -30% | -$203K | ﹤0.01% | 2885 |
|
|
2024
Q4 | $704K | Buy |
74,790
+9,210
| +14% | +$86.7K | ﹤0.01% | 2853 |
|
|
2024
Q3 | $529K | Buy |
65,580
+48,316
| +280% | +$390K | ﹤0.01% | 2962 |
|
|
2024
Q2 | $147K | Sell |
17,264
-27,747
| -62% | -$236K | ﹤0.01% | 3203 |
|
|
2024
Q1 | $404K | Sell |
45,011
-37,346
| -45% | -$335K | ﹤0.01% | 2957 |
|
|
2023
Q4 | $925K | Buy |
82,357
+59,088
| +254% | +$664K | ﹤0.01% | 2653 |
|
|
2023
Q3 | $201K | Sell |
23,269
-5,554
| -19% | -$48K | ﹤0.01% | 3032 |
|
|
2023
Q2 | $298K | Sell |
28,823
-7,779
| -21% | -$80.4K | ﹤0.01% | 2892 |
|
|
2023
Q1 | $397K | Buy |
36,602
+12,979
| +55% | +$141K | ﹤0.01% | 2791 |
|
|
2022
Q4 | $265K | Buy |
23,623
+12,425
| +111% | +$139K | ﹤0.01% | 2955 |
|
|
2022
Q3 | $114K | Sell |
11,198
-9,769
| -47% | -$99.5K | ﹤0.01% | 3368 |
|
|
2022
Q2 | $190K | Sell |
20,967
-7,657
| -27% | -$69.4K | ﹤0.01% | 3157 |
|
|
2022
Q1 | $274K | Sell |
28,624
-65,785
| -70% | -$630K | ﹤0.01% | 3139 |
|
|
2021
Q4 | $1.04M | Buy |
94,409
+35,619
| +61% | +$394K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $435K | Buy |
58,790
+51,922
| +756% | +$384K | ﹤0.01% | 2657 |
|
|
2021
Q2 | $100K | Sell |
6,868
-44,452
| -87% | -$647K | ﹤0.01% | 3138 |
|
|
2021
Q1 | $1.05M | Buy |
51,320
+25,216
| +97% | +$514K | ﹤0.01% | 2276 |
|
|
2020
Q4 | $464K | Sell |
26,104
-17,016
| -39% | -$302K | ﹤0.01% | 2358 |
|
|
2020
Q3 | $637K | Sell |
43,120
-28,124
| -39% | -$415K | ﹤0.01% | 2177 |
|
|
2020
Q2 | $1.5M | Buy |
71,244
+27,721
| +64% | +$582K | ﹤0.01% | 1667 |
|
|
2020
Q1 | $1.01M | Sell |
43,523
-11,185
| -20% | -$258K | ﹤0.01% | 1719 |
|
|
2019
Q4 | $1.42M | Buy |
54,708
+9,628
| +21% | +$249K | ﹤0.01% | 2088 |
|
|
2019
Q3 | $879K | Sell |
45,080
-65,159
| -59% | -$1.27M | ﹤0.01% | 2331 |
|
|
2019
Q2 | $1.8M | Buy |
110,239
+66,146
| +150% | +$1.08M | ﹤0.01% | 1898 |
|
|
2019
Q1 | $1M | Buy |
44,093
+25,341
| +135% | +$575K | ﹤0.01% | 2149 |
|
|
2018
Q4 | $481K | Sell |
18,752
-12,734
| -40% | -$327K | ﹤0.01% | 2281 |
|
|
2018
Q3 | $1.03M | Buy |
31,486
+28,347
| +903% | +$926K | ﹤0.01% | 2240 |
|
|
2018
Q2 | $72K | Sell |
3,139
-8,686
| -73% | -$199K | ﹤0.01% | 3187 |
|
|
2018
Q1 | $286K | Buy |
11,825
+2,933
| +33% | +$70.9K | ﹤0.01% | 2632 |
|
|
2017
Q4 | $248K | Buy |
8,892
+6,562
| +282% | +$183K | ﹤0.01% | 2521 |
|
|
2017
Q3 | $79K | Buy |
2,330
+563
| +32% | +$19.1K | ﹤0.01% | 2793 |
|
|
2017
Q2 | $71K | Sell |
1,767
-14,708
| -89% | -$591K | ﹤0.01% | 2897 |
|
|
2017
Q1 | $607K | Buy |
16,475
+12,857
| +355% | +$474K | ﹤0.01% | 1853 |
|
|
2016
Q4 | $115K | Buy |
3,618
+1,692
| +88% | +$53.8K | ﹤0.01% | 2543 |
|
|
2016
Q3 | $71K | Sell |
1,926
-11,563
| -86% | -$426K | ﹤0.01% | 2579 |
|
|
2016
Q2 | $305K | Buy |
13,489
+13,106
| +3,422% | +$296K | ﹤0.01% | 1961 |
|
|
2016
Q1 | $7K | Sell |
383
-6,667
| -95% | -$122K | ﹤0.01% | 3005 |
|
|
2015
Q4 | $113K | Sell |
7,050
-2,007
| -22% | -$32.2K | ﹤0.01% | 2261 |
|
|
2015
Q3 | $90K | Buy |
9,057
+8,486
| +1,486% | +$84.3K | ﹤0.01% | 2403 |
|
|
2015
Q2 | $7K | Sell |
571
-567
| -50% | -$6.95K | ﹤0.01% | 3465 |
|
|
2015
Q1 | $19K | Sell |
1,138
-3,018
| -73% | -$50.4K | ﹤0.01% | 3134 |
|
|
2014
Q4 | $59K | Buy |
4,156
+724
| +21% | +$10.3K | ﹤0.01% | 2933 |
|
|
2014
Q3 | $80K | Sell |
3,432
-3,641
| -51% | -$84.9K | ﹤0.01% | 2751 |
|
|
2014
Q2 | $220K | Buy |
+7,073
| New | +$220K | ﹤0.01% | 2345 |
|